Last Updated: January 22, 2020
Acadia Pharmaceuticals, Inc. and its U.S. controlled subsidiaries (collectively, “Acadia”, “we”, “our” or “us“) respect your privacy. This Privacy Shield Notice (“Notice”) describes our standards and procedures for handling Personal Information transferred from the European Economic Area (“EEA“) and Switzerland to the U.S. in accordance with Acadia’s obligations under the EU-U.S. and Swiss-U.S. Privacy Shield Frameworks.
Acadia Pharmaceuticals, Inc. and its controlled subsidiaries comply with the EU-U.S. Privacy Shield Framework and Swiss-U.S. Privacy Shield Framework (together the “Privacy Shield”) as set forth by the U.S. Department of Commerce regarding the collection, use, and retention of Personal Information transferred from the EEA member countries, the UK and Switzerland to the United States. Acadia Pharmaceuticals, Inc. has certified to the Department of Commerce that it adheres to the Privacy Shield Principles of Notice, Choice, Accountability for Onward Transfer, Security, Data Integrity and Purpose Limitation, Access and Recourse, Enforcement and Liability (collectively, the “Principles”). If there is any conflict between the terms in this Notice and the Principles, the Principles shall govern. To learn more about the Privacy Shield program, and to view our certification, please visit https://www.privacyshield.gov/.
This Notice supplements Acadia’s Privacy Policy (“Privacy Policy”). Unless specifically defined in this Notice, the capitalized terms in this Notice have the same meaning as those capitalized terms provided in our Privacy Policy.
We obtain and process Personal Information from the EEA and Switzerland in different capacities as provided in our online Privacy Policy. This Privacy Policy describes the categories of Personal Information we may receive in the United States, as well as the purposes for which we use that Personal Information. We will only process Personal Information in ways that are compatible with the purpose we collected it for, or for the purposes you later authorize. Acadia commits to comply with the Principles with respect to all Personal Information received from the EEA and Switzerland in reliance on the Privacy Shield, as we further describe below.
Amendment. This Notice may be amended consistent with the requirements of the EU-U.S. and Swiss-U.S. Privacy Shield Frameworks. When we update this Notice, we will also revise the “Last Updated” date at the top of this document.
Questions or Complaints. In compliance with the Principles, Acadia commits to resolve complaints about our collection or use of your Personal Information. EU and Swiss individuals with inquiries or complaints regarding our Privacy Shield Notice should first contact Acadia at privacy@acadia-pharm.com or by postal mail at:
Acadia Pharmaceuticals, Inc.
Attn: Privacy Shield Inquiry
12830 El Camino Real, Suite 400
San Diego, California, 92130
This website uses cookies to improve and customize your experience on our website. By using this website without changing your cookie settings in your browser, you agree to our use of cookies. For further details on cookies, how we use cookies and how to delete or block the use of cookies, please read our Cookie Policy.
ACCEPT